About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04230200

Prospective Screening Programme for Malignant Tumors

In prospective part of study, the investigators have found that the parameters of routine blood tests can differentiate varieties of malignancy from healthy people. The investigators enrolled healthy...

Lead sponsor: Sun Yat-sen University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sun Yat-sen University

Collaborators

First Affiliated Hospital, Sun Yat-Sen University
Sixth Affiliated Hospital, Sun Yat-sen University

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•For the cohort of healthy people
•1. Asymptomatic persons between the ages of 18 to 80 years
•2. Chinese ethnicity
•3. After 3 year follow-up, diagnosed with no malignant disease
•4. Subject underwent routine blood tests in our center
•1. diagnosis with the following malignant disease，breast cancer, lung cancer, gastric cancer， esophageal cancer，colorectal cancer，nasopharyngeal cancer，liver cancer and cervical cancer
•2. Subject underwent routine blood tests in our center

Exclusion Criteria

•1.With a history of malignant disease
•For the cohort of patients with malignancy

Related studies

Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies

NCT06426992 · Liver Malignant Tumors

RECRUITINGPhase 1

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

NCT06759649 · Neoplasm, Cancer, Malignant Tumors

Rehabilitation Outcomes Study

NCT06674889 · Cancer, Malignant Tumor

RECRUITINGPhase 1/2

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

NCT07399769 · Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)

RECRUITINGPhase 1/2

First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors

NCT06877650 · Advanced Malignant Tumors

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 22, 2020Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment10,000

Start dateMar 2017

Last updatedJan 22, 2020

Condition

Hematologic Tests Malignant Tumor

Locations shown

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 22, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions